High uptake of RSVpreF vaccine and nirsevimab was observed, with 64% of pregnant individuals and 70% of infants receiving ...

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on ...

A nationwide surge in flu, COVID-19, RSV and norovirus infections is fueling concerns of a possible virus "quademic." Or is it just winter? The three respiratory viruses plus norovirus ...

Generally, innate cellular immunity against virus infection is primarily mediated by IFN-I, which then exerts the pleiotropic effects by inducing a variety of IFN-stimulated genes (ISGs). Unique viral ...

We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, ...

Despite its extensive use and popularity, aspartame has become a source of controversy in recent years, with some research suggesting the sweetener has adverse health effects. It is not clear if ...

Prior to the introduction of respiratory syncytial virus (RSV) vaccines, RSV was linked to a substantial burden of hospitalizations, admissions to the intensive care unit, and in-hospital deaths among ...

Halifax pediatric infectious disease physician Joanne Langley said the study shows why it's crucial to examine the effects of policy changes and to prevent infants from contracting RSV.

While the number of COVID diagnoses are down compared with this time last year, other illnesses such as the norovirus stomach bug, RSV and whooping cough saw an increase in cases in the last few ...